DMK Pharmaceuticals
Gladstone
About DMK Pharmaceuticals
DMK Pharmaceuticals help the patients to overcome with central nervous disorders could live their lives in control, rather than being controlled by their addiction, chronic pain, Parkinson's disease, depression, bladder problems - or their treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Last round: Grant (Jun 2023)
- Website: dmkpharma.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/dmk-pharmaceuticals-181635 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.